The power of artificial intelligence (AI) in medicine lies in its ability to find important statistical patterns in large datasets. A recently published study is an important proof of concept for how AI can help doctors and brain tumour patients make better treatment decisions.
Meningiomas – tumours that arise from the membranes that surround the brain and spinal cord – are the most common primary central nervous system tumour, with an incidence of 8.14 per 100,000 population. While they generally have better outcomes than other brain tumours, there is a great deal of variability in aggressiveness. Being able to predict malignancy and accurately estimate survival is therefore incredibly important in deciding whether surgery is the best option for the patient.